ZYNE

Zynerba Pharmaceuticals, Inc
ZYNE

Overview Fund Activity
Delisted

ZYNE was delisted on the 10th of October, 2023.

Back to rankings

66 hedge funds and large institutions have $16.2M invested in Zynerba Pharmaceuticals, Inc in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 29 reducing their positions, and 21 closing their positions.

Holders
66
Holders Change
-8
Holders Change %
-10.81%
% of All Funds
1.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
13
Reduced
29
Closed
21
Calls
$1.4M
Puts
$1.24M
Net Calls
+$157K
Net Calls Change
-$643K

Top Buyers

1
Mirae Asset Global Investments
1
Mirae Asset Global Investments
South Korea
$1.35M
2
Walleye Capital
2
Walleye Capital
New York
$171K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$339K
4
Group One Trading
4
Group One Trading
Illinois
$137K
5
JWCA
5
J.W. Cole Advisors
Florida
$123K

Top Sellers

1
IC
1
Ikarian Capital
Texas
$0
2
ZCA
2
Zeke Capital Advisors
Pennsylvania
$165K
3
EMG
3
ETF Managers Group
New Jersey
$2.95M
4
ECM
4
ExodusPoint Capital Management
New York
$0
5
Jane Street
5
Jane Street
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PCM
76
Prelude Capital Management
New York
– -$6K -1,769 Closed
CL
77
CSS LLC
Illinois
– -$4K -1,200 Closed
Bank of Montreal
78
Bank of Montreal
Ontario, Canada
– -$3K -967 Closed
APA
79
American Portfolios Advisors
New York
– -$1.44K -428 Closed
PAG
80
Private Advisor Group
New Jersey
– -$1K -291 Closed
Deutsche Bank
81
Deutsche Bank
Germany
– -$1K -200 Closed
CIAS
82
CBIZ Investment Advisory Services
Ohio
– -$1K – –
1 2 3
4